| 000 | 01627 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514005259.0 | ||
| 264 | 0 | _c20011025 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200108170-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoletar, S L | |
| 245 | 0 | 0 |
_aA prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cAug 2001 |
||
| 300 |
_a1509-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xprevention & control |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPneumonia, Pneumocystis _xprevention & control |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aHeald, A E | |
| 700 | 1 | _aFinkelstein, D | |
| 700 | 1 | _aHafner, R | |
| 700 | 1 | _aCurrier, J S | |
| 700 | 1 | _aMcCutchan, J A | |
| 700 | 1 | _aVallee, M | |
| 700 | 1 | _aTorriani, F J | |
| 700 | 1 | _aPowderly, W G | |
| 700 | 1 | _aFass, R J | |
| 700 | 1 | _aMurphy, R L | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 15 _gno. 12 _gp. 1509-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200108170-00008 _zAvailable from publisher's website |
| 999 |
_c11430085 _d11430085 |
||